Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS
Abroad (travel likely)RecruitingPHASE4
Conditions
aHUS · Atypical Hemolytic Uremic Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Research Site, Bunkyō City, Japan
Research Site, Hirakata-shi, Japan
Research Site, Iruma-Gun, Japan
Research Site, Kyoto, Japan
Research Site, Matsumoto-shi, Japan
Research Site, Miyazaki, Japan
Research Site, Nagoya, Japan
Research Site, Nara, Japan
Research Site, Nerima-ku, Japan
Research Site, Sapporo, Japan
Research Site, Shinjuku-ku, Japan
Research Site, Tsu, Japan